NOV 20, 2019 4:49 PM PST

Harnessing the Power of Natural Killer Cells to Fight Cancer

WRITTEN BY: Kara Marker

Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results investigating the cells in mice, and scientists show that human cells share the same promising physiological responses.

NK cells (brown) patrolling between cells of a healthy human lymph node. Source: Institute of Pathology, University of Bern

NK cells (brown) patrolling between cells of a healthy human lymph node. Source: Institute of Pathology, University of Bern

 

Natural killer (NK) cells are key components of the innate immune system, the arm of human immunity that responds first to pathogenic invasions with a non-specific attack. That attack could be via virus or cancer, but either way, NK cells seek to eliminate affected cells before the affliction has a chance to spread. They can do this one of two ways: release cell toxins for a direct kill, or activate cells affected by cancer or virus to self-destruct, a process called apoptosis.

During a viral invasion, NK cells manage T cells of the adaptive immune system, the second, more specific phase of immune response, by preventing them from unnecessarily killing host cells unaffected by the virus. NK cells do this by releasing “messenger molecules” to support immune defense.

But scientists from the recent study are presently more interested in NK cell-induced cellular self-destruction and its potential ability to improve anti-cancer clinical tactics. Researchers put “death ligands” under the microscope, scrutinizing these surface proteins’ abilities of interacting with “corresponding receptors” on the surface of target cells. One death ligand stood out during the study, a protein called “tumor necrosis factor-related apoptosis-inducing ligand,” or “TRAIL.”

Cancerous cells are more sensitive to TRAIL stimulation than healthy cells, making TRAIL-related therapies potential options for initiating the apoptotic self-destruction of cancer cells. One roadblock seems to stand in the way: in past studies, TRAIL has also been associated with negative health outcomes in particular infection cases. The present study offers a solution for navigating around this roadblock to effectively utilize TRAIL as an anti-cancer tactic.

Researchers began by studying the TRAIL response in a murine model of viral infection. Mice whose NK cells did not have TRAIL were better equipped to fight the virus than mice whose TRAIL was fully intact. NK cells perceived cellular signaling differently when they lacked TRAIL; they did less killing and more messenger molecule production, and T cells subsequently became more protective and were able to better remove virally infected cells. Researchers saw signs of similar activity in human NK cells too, indicating a potential for the reprogramming of NK cells to better target cancerous cells in addition to virally infected cells.

Sources: University of Bern, European Molecular Biology Organization (EMBO) Reports

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 13, 2020
Drug Discovery & Development
Fecal Transplant Helps Fight off Antibiotic Resistance
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
JUN 04, 2020
Clinical & Molecular DX
Low T Cells Linked To High COVID Risk
JUN 04, 2020
Low T Cells Linked To High COVID Risk
  German scientists have found a link between immune cell counts and the risk of developing severe, potentially lif ...
JUN 20, 2020
Immunology
A Cell's 450 Million Year Journey
JUN 20, 2020
A Cell's 450 Million Year Journey
Microglia make up just a fraction of all the cells in the brain, but play a vital role in removing pathogens or damaged ...
JUL 15, 2020
Immunology
Immune Memory to Thwart Recurring Cancer
JUL 15, 2020
Immune Memory to Thwart Recurring Cancer
Preventing cancer from returning in the body is an integral part of any anti-cancer treatment plan. New discoveries from ...
JUL 30, 2020
Genetics & Genomics
How Are DNA Testing Companies Helping the Fight Against COVID?
JUL 30, 2020
How Are DNA Testing Companies Helping the Fight Against COVID?
One of the most puzzling characteristics of coronavirus is how some people develop severe symptoms and die from the dise ...
JUL 29, 2020
Immunology
Immune Variation Explains Different COVID-19 Outcomes
JUL 29, 2020
Immune Variation Explains Different COVID-19 Outcomes
Immune systems respond differently to coronavirus infection. People experience the disease causes by coronavirus, COVID- ...
Loading Comments...